Make every Performance

Sensitivity*
testing
Product Information
100% Method Lateral flow

opportunity Specificity
99.72%
Time to results

Storage conditions
20 minutes

2-30°C

count. *Please refer to the Product Insert for the analytical

sensitivity of HIV-1 p24 Antigen.
Sample volume

Test shelf life

50µl

18 months

Sample types Serum/plasma, fingerstick

whole blood and
venipuncture whole blood

New possibilities in patient care

By closing the window period Alere HIV Combo TM

Order info
sets a new standard in point of care testing.
This simple test delivers fast, accurate results Product Catalogue Number
in 20 minutes introducing new possibilities in
patient care. Alere HIV Combo
TM

7D2846
20 test kit

Alere HIV Combo

TM

7D2847
100 test kit

5-20%
Chase Buffer 7D2243
Acute infection accounts for
EDTA Capillary Tubes 7D2227
(mylar wrapped)

1. Branson, B and Stekler, J. D, Detection of Acute HIV Infection; We can't close the window, Journal of Infectious Disease, 2012, 205: 521-4.
2. Francine E. McCutchan, Henry M. Jackson Foundation (Rockville, Maryland). IAVI Report, August 2003 [online] available at
http://www.pbs.org/wgbh/pages/frontline/aids/atlas/clade.html.
3. Alere HIV Combo Product Insert. Data on file.

of all cases of HIV infection among persons seeking testing.1 For more information, contact your local Alere representative or visit alerehiv.com

Otros - Latinoamérica y Caribe

This acute phase of infection is associated with peak levels of viremia and high risk of transmission.
By quickly and accurately identifying HIV positive patients earlier, this will increase case finding and
facilitate fast and appropriate linkage to care.
+1-877-441-7440 Opción 4
LATAMCustomerSupport@alere.com
© 2016 Alere. All rights reserved. The Alere Logo, Alere and Knowing now matters are trademarks of the Alere group of companies.
Photos are used for illustrative purposes only. Any person depicted in the photos is a model. 120001735-06 06/16
A new standard in HIV screening A pathway to
improved prognosis
Alere HIV Combo is an in vitro, visually read, qualitative
with 4th generation Distribution of HIV-1
point-of-care testing Subtypes in Europe2
TM

lateral flow immunoassay for the simultaneous detection

of free non immunocomplexed HIV-1 p24 antigen (Ag)
and antibodies (Ab) to HIV-1 and HIV-2 in human blood.
The test specimen can be serum, plasma, fingerstick or
venous whole blood.

It detects more acute

infections compared to
2nd and 3rd generation tests
which helps close the
window period and enables
increased case finding at
a time when individuals
are highly infectious.

B A, B, AB recombinant C
Days Months Years
CRF02_AG, other recombinants B, C, BC recombinant D
Additional HIV-1 p24 HIV-1/2 antibodies
Window antigen F, G, H, J, K, CRF01 A Insufficient
other recombinants Data

HIV-1 antigens HIV antibodies

 HIV-1 group M subtype A, B, C, D, F, G, H and  HIV-1 group M subtype A, B, C, D, F, G, H,

CRF01-AE, CRF02-AG, and HIV-1 group O J, K, CRF01-AE , CRF02-AG, CRF03-AB

High viral load & infection risk are all detectable with Alere HIV Combo.3
TM
CRF05-DF, CRF09-A/U, CRF11-cpx, HIV-1
group O and HIV-2 are all detectable with
3rd Generation Rapid Test HIV-1/2 Antibody only tests
Alere HIV Combo.3
TM

4th Generation Alere HIV Combo: HIV-1 p24 Antigen + HIV-1/2 Antibodies on a single POC test strip*
TM

Rapid Test

0 12 20 26 45
Days of infection

*Not comparable to molecular testing